Prempro

Many women suffer the effects of menopause which can make daily life more difficult, and the physical complications that are often associated with this part of life are taxing on the millions of women who suffer them daily. With such a large scope of potential consumers in need of relief from uncomfortable, sometimes nearly unbearable symptoms, the need to provide a satisfactory product that would alleviate such symptoms was obvious. This came in the form of hormone therapy.

Wyeth Pharmaceuticals developed a hormone replacement product named Prempro to fill a void and bring the much-needed relief to women suffering through the difficult years of menopause. Although Prempro was first approved by the Federal Food and Drug Administration in 1995, the drug had never undergone a randomized clinical trail that would later reveal a devastating flaw in the testing and approval process.

Prempro, since its approval by the FDA, has become the most widely prescribed menopause relief drug in the United States and millions of women have become daily users of the drug for years. However, this trend has since been reversed because of the findings of a clinical trial conducted by the National Institute of Health that had to be halted before its scheduled ending date because of the obvious and overwhelming health risks posed to those in the trial. In January 2003, the drug was given a "black box warning" by the FDA which is the highest level of warning to be given to any drug allowed to remain on the market

Prempro has now been identified as the major factor for the increased risk of many significant and life-threatening health problems in women taking the drug for several years. The risk of the following health problems is substantially increased for those having taken Prempro for several years:

  • Heart attack
  • Stroke
  • Breast cancer (also cases of ovarian and uterine cancer)
  • Pulmonary embolism
  • Blood clots

On February 20, 2007, a jury awarded $3 million to a woman having suffered greatly due to the undisclosed long-term effects of the dangerous drug. Wyeth Pharmaceuticals has been marshalling legal forces in preparation for necessary defense against the many cases that will certainly arise as they come to light in the near future.

Messa & Associates has the knowledge and expertise to fight the pharmaceutical companies that have taken advantage of consumers. The professional ability and legal excellence of Messa & Associates combined with their experience fighting for those who have been harmed by a defective drug makes them the first choice for women with problems that are likely caused by prolonged use of Prempro. A free consultation is available with a defective drug attorney at Messa & Associates at the toll-free number provided. Call today and get an evaluation of your case from a professional who is compassionate and knowledgeable.

If you have been injured, contact Joseph Messa, Jr, a Philadelphia personal injury lawyer and a New Jersey personal injury lawyer, at his offices in Philadelphia, Pennsylvania and in New Jersey. We serve all communities throughout Philadelphia, Pennsylvania and New Jersey. If you or a loved one has been the victim of a Birth Injury, Construction Accident Injury, Truck Accident Injury, or Airplane Injury, please complete a FREE consultation form or call our law firm today.

© Copyright 2010 Messa & Associates, P.C. | Site Map